These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1919652)

  • 1. Enoxacin therapy for experimental pseudomonas keratitis.
    Esposito S; Thadepalli H; Benler HA; Chuah SK
    J Chemother; 1991 Jun; 3(3):147-51. PubMed ID: 1919652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of experimental Pseudomonas corneal ulcers with enoxacin, a quinolone antibiotic.
    Sugar A; Cohen MA; Bien PA; Griffin TJ; Heifetz CL; Mehta S
    Arch Ophthalmol; 1986 Aug; 104(8):1230-2. PubMed ID: 3461752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of experimental bacterial keratitis with topical trovafloxacin.
    Barequet IS; Denton P; Osterhout GJ; Tuli S; O'Brien TP
    Arch Ophthalmol; 2004 Jan; 122(1):65-9. PubMed ID: 14718297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keratotomy model of pseudomonas keratitis: gentamicin chemotherapy.
    Brockman EB; Tarantino PA; Hobden JA; Hill JM; O'Callaghan RJ; Kaufman HE; Insler MS
    Refract Corneal Surg; 1992; 8(1):39-43. PubMed ID: 1554638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of ophthalmic gatifloxacin 0.3% and ciprofloxacin 0.3% in healing of corneal ulcers associated with Pseudomonas aeruginosa-induced ulcerative keratitis in rabbits.
    Jensen H; Zerouala C; Carrier M; Short B
    J Ocul Pharmacol Ther; 2005 Feb; 21(1):36-43. PubMed ID: 15718826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of experimental Pseudomonas aeruginosa keratitis.
    Guzek JP; Chacko D; Kettering JD; Wessels IF; Aprecio RM
    Cornea; 1994 Nov; 13(6):500-4. PubMed ID: 7842708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nona-D-arginine amide for prophylaxis and treatment of experimental Pseudomonas aeruginosa keratitis.
    Karicherla P; Hobden JA
    Curr Eye Res; 2010 Mar; 35(3):220-4. PubMed ID: 20373880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis.
    Mannis MJ
    Trans Am Ophthalmol Soc; 2002; 100():243-71. PubMed ID: 12545697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of besifloxacin, gatifloxacin, and moxifloxacin against strains of pseudomonas aeruginosa with different quinolone susceptibility patterns in a rabbit model of keratitis.
    Sanders ME; Moore QC; Norcross EW; Sanfilippo CM; Hesje CK; Shafiee A; Marquart ME
    Cornea; 2011 Jan; 30(1):83-90. PubMed ID: 20847656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciprofloxacin-resistant Pseudomonas keratitis.
    Garg P; Sharma S; Rao GN
    Ophthalmology; 1999 Jul; 106(7):1319-23. PubMed ID: 10406614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perineural infiltrates in Pseudomonas keratitis.
    Robbie SJ; Vega FA; Tint NL; Hau S; Allan B
    J Cataract Refract Surg; 2013 Nov; 39(11):1764-7. PubMed ID: 24160385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study on topical and oral administration of ofloxacin for Pseudomonas corneal ulcer in rabbits.
    Shiao S; Isobe Y; Hatano H; Ohno S
    Ophthalmologica; 1995; 209(3):155-9. PubMed ID: 7630623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic phenotype and genotype of Pseudomonas aeruginosa isolates from spontaneous canine ocular infections.
    Ledbetter EC; Mun JJ; Kowbel D; Fleiszig SM
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):729-36. PubMed ID: 18836164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Povidone-iodine (betadine) in the treatment of experimental Pseudomonas aeruginosa keratitis.
    Michalová K; Moyes AL; Cameron S; Juni BA; Obritsch WF; Dvorak JA; Doughman DJ; Rhame FS
    Cornea; 1996 Sep; 15(5):533-6. PubMed ID: 8862931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones.
    Alexandrakis G; Alfonso EC; Miller D
    Ophthalmology; 2000 Aug; 107(8):1497-502. PubMed ID: 10919897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiresistant Pseudomonas keratitis.
    Ku JY; Kim P; Tong J; Wechsler A; McCluskey P
    Clin Exp Ophthalmol; 2010 Nov; 38(8):818-9. PubMed ID: 20572829
    [No Abstract]   [Full Text] [Related]  

  • 17. Topical norfloxacin therapy in Pseudomonas corneal ulceration.
    Vajpayee RB; Gupta SK; Angra SK; Munjal A
    Cornea; 1991 May; 10(3):268-71. PubMed ID: 2055033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zymar (Gatifloxacin 0.3%) shows excellent Gram-negative activity against Serratia marcescens and Pseudomonas aeruginosa in a New Zealand White rabbit keratitis model.
    Mah FS; Romanowski EG; Kowalski RP; Yates KA; Gordon YJ
    Cornea; 2007 Jun; 26(5):585-8. PubMed ID: 17525656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of topical colistin in multiple drug-resistant Pseudomonas aeruginosa bacterial keratitis.
    Jain R; Murthy SI; Motukupally SR; Jain M
    Cornea; 2014 Sep; 33(9):923-7. PubMed ID: 25014142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prednisolone acetate or prednisolone phosphate concurrently administered with ciprofloxacin for the therapy of experimental Pseudomonas aeruginosa keratitis.
    Hobden JA; Engel LS; Hill JM; Callegan MC; O'Callaghan RJ
    Curr Eye Res; 1993 May; 12(5):469-73. PubMed ID: 8344070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.